KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Non-Current Debt (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Non-Current Debt for 17 consecutive years, with $5.2 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Debt fell 7.98% to $5.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 billion through Dec 2025, down 7.98% year-over-year, with the annual reading at $5.2 billion for FY2025, 7.98% down from the prior year.
  • Non-Current Debt hit $5.2 billion in Q4 2025 for Quest Diagnostics, roughly flat from $5.2 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $5.9 billion in Q1 2025 to a low of $3.8 billion in Q2 2023.
  • Historically, Non-Current Debt has averaged $4.4 billion across 5 years, with a median of $4.0 billion in 2021.
  • Biggest YoY gain for Non-Current Debt was 54.0% in 2025; the steepest drop was 8.45% in 2025.
  • Year by year, Non-Current Debt stood at $4.0 billion in 2021, then dropped by 0.8% to $4.0 billion in 2022, then increased by 10.86% to $4.4 billion in 2023, then rose by 27.32% to $5.6 billion in 2024, then decreased by 7.98% to $5.2 billion in 2025.
  • Business Quant data shows Non-Current Debt for DGX at $5.2 billion in Q4 2025, $5.2 billion in Q3 2025, and $5.2 billion in Q2 2025.